Blood Marker Linked to Heart Risk May Be Influenced by Omega-3 Levels
This large study followed over 42,000 adults in the UK Biobank who did not have existing heart disease or heart failure at the start. Researchers measured a blood protein called heart-type fatty acid-binding protein (H-FABP), which is involved in moving fat molecules inside cells and has previously been used as an early marker for heart attacks.
Over time, people with higher H-FABP levels had a notably greater risk of developing coronary heart disease, heart attacks, dying from heart-related causes, and developing heart failure. The associations were consistent and grew stronger for more severe outcomes like cardiac death and heart failure.
The researchers also looked at whether omega-3 fatty acid levels interacted with this risk marker, suggesting that fatty acid status may play a role in how this protein relates to long-term heart outcomes in the general population.
What this means for you
This research highlights a blood marker that may help identify people at higher long-term risk for heart problems, and suggests omega-3 fatty acid status could be a relevant factor to consider alongside it. It does not test or prove that omega-3 supplementation changes this risk, so more targeted research is needed before drawing conclusions about prevention or treatment.
Ready to start? The ALP Protocol delivers the EPA & DHA doses used in the research.
Start the ALP ProtocolSource
Heart (British Cardiac Society) · 2026-10-01 · DOI: 10.1136/heartjnl-2026-327893
Read the original source ↗This summary is for educational purposes only and is not medical advice. Always talk to your healthcare provider before making changes to your supplement routine.